Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,4-oxadiazole incorporated indazole-isoxazole derivatives

References

• Taylor, R. D.; MacCoss, M.; Lawson, A. D. G. Rings in Drugs. J. Med. Chem. 2017, 60, 1638–1647. DOI: 10.1021/acs.jmedchem.6b01367.
   PubMedGoogle Scholar
• Wen, L.; Sun, Q.; Zhang, H.; Li, M. A New Rapid Multicomponent Domino Hetero Annulation of Heterocyclic Ketene Aminals: solvent-Free Regioselective Synthesis of Functionalized Benzo[g]Imidazo[1,2-a]Quinolinediones. Org. Biomol. Chem. 2013, 11, 781–786. DOI: 10.1039/c2ob27137k.
   PubMed Web of Science ®Google Scholar
• Bandaru, C. M.; Poojith, N.; Jadav, S. S.; Rao, M. V. B.; Babu, K. S.; Sreenivasulu, R.; Alluri, R. Design, Synthesis, Anticancer Evaluation and Molecular Docking Studies of Thiazole-Pyrimidine Linked Amide Derivatives. Polycycl. Aromat. Compd 2022, 42, 5368–5384. DOI: 10.1080/10406638.2021.1939067.
   Web of Science ®Google Scholar
• Rosenker, K. M. G.; Paquette, W. D.; Johnston, P. A.; Sharlow, E. R.; Andreas, V.; Bakan, A.; Lazo, J. S.; Wipf, P. Synthesis and Biological Evaluation of 3-Aminoiso Quinolin-1(2H)-One Based Inhibitors of the Dual-Specificity Phosphatase Cdc25B. Bioorg. Med. Chem. 2015, 23, 2810–2818. DOI: 10.1016/j.bmc.2015.01.043.
   PubMedGoogle Scholar
• Buchel, G. E.; Stepanenko, IN.; Hejl, M.; Jakupec, M. A.; Keppler, B. K.; Heffeter, P.; Berger, W.; Arion, V. B. Osmium (IV) Complexes with 1H- and 2H-Indazoles: Tautomer Identity versus Spectroscopic Properties and Antiproliferative Activity. J. Inorg. Biochem. 2012, 113, 47–54. DOI: 10.1016/j.jinorgbio.2012.04.001.
   PubMed Web of Science ®Google Scholar
• Raffa, D.; Maggio, B.; Cascioferro, S.; Raimondi, M. V.; Schillaci, D.; Gallo, G.; Daidone, S.; Plescia, F.; Meneghetti, G.; Bombieri, A. D.; et al. Synthesis and Antiproliferative Activity of 3-amino-N-Phenyl-1H-Indazole-1-Carboxamides. Eur. J. Med. Chem. 2009, 44, 165–178. DOI: 10.1016/j.ejmech.2008.03.023.
   PubMedGoogle Scholar
• Mosti, L.; Menozzi, G.; Fossa, P.; Schenone, P.; Lampa, E.; Parrillo, C.; D'Amisco, M.; Rossi, F. 4-substituted 1-Methyl-1H-Indazoles with Analgesic, Antiinflammatory and Antipyretic Activities. Farmaco 1992, 47, 567–584.
   PubMedGoogle Scholar
• Bermudez, J.; Fake, C. S.; Joiner, G. F.; Joiner, K. A.; King, F. D.; Miner, W. D.; Sanger, G. J. 5-Hydroxytryptamine (5-HT3) Receptor Antagonists. 1. Indazole and Indolizine-3-Carboxylic Acid Derivatives. J. Med. Chem. 1990, 33, 1924–1929. DOI: 10.1021/jm00169a016.
   PubMed Web of Science ®Google Scholar
• Rodgers, J. D.; Johnson, B. L.; Wang, H.; Greenberg, R. A.; Erickson-Viitanen, S.; Klabe, R. M.; Cordova, B. C.; Rayner, M. M.; Lam, G. N.; Chang, C. H. Potent Cyclic Urea HIV Protease Inhibitors with Benzofused Heterocycles as P2/P2′ Groups. Bioorg. Med. Chem. Lett 1996, 6, 2919–2924. DOI: 10.1016/S0960-894X(96)00531-8.
   Web of Science ®Google Scholar
• Giorgio, G.; Palazzo, G.; Germani, C.; Barcellona, P. S.; Silvestrini, B. 1-Halobenzyl-1H-Indazole-3-Carboxylic Acids. A New Class of Antispermatogenic Agents. J. Med. Chem. 1976, 19, 778–783. DOI: 10.1021/jm00228a008.
   PubMed Web of Science ®Google Scholar
• Lee, F. Y.; Lien, J. C.; Huang, L. J.; Huang, T. M.; Tsai, S. C.; Teng, C. M.; Wu, C. C.; Cheng, F. C.; Kuo, S. C. Synthesis of 1-Benzyl-3-(5’-Hydroxymethyl-2’-Furyl)Indazole Analo Gues as Novel Antiplatelet Agents. J. Med. Chem. 2001, 44, 3746–3749. DOI: 10.1021/jm010001h.
   PubMed Web of Science ®Google Scholar
• Kevin, G.; Albert, J.; Robichaud, A.; Alexander, A.; Greenfield, A.; Lo, J. R.; Grosanu, C.; Mattes, J. F.; Cai, Y.; Zhang, G. M.; et al. Identification of 3-Sulfonylindazole Derivatives as Potent and Selective 5-HT6 Antagonists. Bioorg. Med. Chem. 2011, 19, 650–662. DOI: 10.1016/j.bmc.2010.10.033.
   PubMed Web of Science ®Google Scholar
• Upadhyay, A.; Srivastava, S.; Yadav, R. Conventional as Well as Microwave Assisted Synthesis and Antimicrobial Screening of 4-Aryl-3-Chloro-1-[(5-Nitroindazol-1-yl)Aceta Mido]-2-Oxo-Azetidines. Indian J. Chem. 2011, 50B, 89–97.
   Google Scholar
• Liu, J.; Peng, X.; Dai, Y.; Zhang, W.; Ren, S.; Ai, J.; Geng, M.; Li, Y. Design, Synthesis and Biological Evaluation of Novel FGFR Inhibitors Bearing an Indazole Scaffold. Org. Biomol. Chem. 2015, 13, 7643–7654. DOI: 10.1039/C5OB00778J.
   PubMed Web of Science ®Google Scholar
• Govek, S. P.; Nagasawa, J. Y.; Douglas, K. L.; Lai, A. G.; Kahraman, M.; Bonnefous, C.; Aparicio, A. M.; Darimont, B. D.; Grillot, K. L.; Joseph, J. D.; et al. Optimization of an Indazole Series of Selective Estrogen Receptor Degraders: Tumor Regression in a Tamoxifen-Resistant Breast Cancer Xenograft. Bioorg. Med. Chem. Lett. 2015, 25, 5163–5167. DOI: 10.1016/j.bmcl.2015.09.074.
   PubMed Web of Science ®Google Scholar
• Vyas, D. H.; Tala, S. D.; Akbari, J. D.; Dhaduk, M. K.; Joshi, H. S. Synthesis, Antimicrobial and Antitubercular Activity of Some Cyclohexenone and Indazole Derivatives. Indian J. Chem. 2009, 48B, 1405–1410.
   Google Scholar
• Ikeda, Y.; Takano, N.; Matsushita, H.; Shiraki, Y.; Koide, T.; Nagashima, R.; Fujimura, Y.; Shindo, M.; Suzuki, S.; Iwasaki, T. Pharmacological Studies on a New Thymoleptic Antidepressant, 1-[3-(Dimethylamino)Propyl]-5-Methyl-3-Phenyl-1H-Indazole (FS-32). Arzneimittelforschung Drug Res. 1979, 29, 511–520.
   Google Scholar
• Song, P.; Chen, M.; Ma, X.; Xu, L.; Liu, T.; Zhou, Y.; Hu, Y. Identification of Novel Inhibitors of Aurora a with a 3-(Pyrrolopyridin-2-yl)Indazole Scaffold. Bioorg. Med. Chem. 2015, 23, 1858–1868. DOI: 10.1016/j.bmc.2015.02.004.
   PubMed Web of Science ®Google Scholar
• Maggio, B.; Raimondi, M. V.; Raffa, D.; Plescia, F.; Cascioferro, S.; Plescia, S.; Tolomeo, M.; Di Cristina, A.; Pipitone, R. M.; Grimaudo, S.; Daidone, G. Synthesis of Substituted 3-amino-N-Phenyl-1H-Indazole-1-Carboxamides Endowed with Antiproliferative Activity. Eur. J. Med. Chem. 2011, 46, 168–174. DOI: 10.1016/j.ejmech.2010.10.032.
   PubMed Web of Science ®Google Scholar
• Salvatore, P.; Demetrio, R.; Fabiana, P.; Casula, G.; Maggio, B.; Daidone, G.; Raimondi, M. V.; Cusimano, M. G.; Bombieri, G.; Meneghetti, F. Synthesis and Biological Evaluation of New Indazole Derivatives. Arkivoc 2010, 2010, 163–177. DOI: 10.3998/ark.5550190.0011.a14.
   Google Scholar
• Albert, D. H.; Tapang, P.; Magoc, T. J.; Pease, L. J.; Reuter, D. R.; Wei, R. Q.; Li, J.; Guo, J.; Bousquet, P. F.; Ghoreishi-Haack, N. S.; et al. Preclinical Activity of ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor. Mol. Cancer Ther. 2006, 5, 995–1006. DOI: 10.1158/1535-7163.MCT-05-0410.
   PubMed Web of Science ®Google Scholar
• Dietrich, J.; Hulme, C.; Hurley, L. H. The Design, Synthesis, and Evaluation of 8 Hybrid DFG-out Allosteric Kinase Inhibitors: A Structural Analysis of the Binding Interactions of Gleevec®, Nexavar®, and BIRB-796. Bioorg. Med. Chem. 2010, 18, 5738–5748. DOI: 10.1016/j.bmc.2010.05.063.
   PubMed Web of Science ®Google Scholar
• Hemming, K.; Alan, R. K.; Christopher, A. R.; Eric, F. V. S.; Richard, J. K. T. (Eds.), Comprehensive Heterocyclic Chemistry III; Elsevier: Oxford, 2008; pp 243–314.
   Google Scholar
• Kiss, L. E.; Ferreira, H. S.; Torrao, L.; Bonifacio, M. J.; Palma, P. N.; Soares-da-Silva, P.; Learmonth, D. A. Discovery of a Long-Acting, Peripherally Selective Inhibitor of catechol-O-Methyltransferase. J. Med. Chem. 2010, 53, 3396–3411. DOI: 10.1021/jm1001524.
   PubMed Web of Science ®Google Scholar
• Haugwitz, R. D.; Martinez, A. J.; Venslavsky, J.; Angel, R. G.; Maurer, B. V.; Jacobs, G. A.; Narayanan, V. L.; Cruthers, L. R.; Szanto, J. Antiparasitic Agents. 6. Synthesis and Anthelmintic Activities of Novel Isothiocyanatophenyl-1,2,4-Oxadiazoles. J. Med. Chem. 1985, 28, 1234–1241. DOI: 10.1021/jm00147a019.
   PubMed Web of Science ®Google Scholar
• Boys, M.; Schretzman, L.; Chandrakumar, N.; Tollefson, M.; Mohler, S.; Downs, V.; Penning, T.; Russell, M.; Wendt, J.; Chen, B.; et al. Convergent, Parallel Synthesis of a Series of β-Substituted 1,2,4-Oxadiazole Butanoic Acids as Potent and Selective αvβ3 Receptor Antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 839–844. DOI: 10.1016/j.bmcl.2005.11.008.
   PubMed Web of Science ®Google Scholar
• Antunes, R.; Batista, H.; Srivastava, R. M.; Thomas, G.; Araujo, C. C.; Longo, R. L.; Magalhaes, H.; Leao, M. B. C.; Pava, A. C. Synthesis, Characterization and Interaction Mechanism of New Oxadiazolo-Phthalimides as Peripheral Analgesics IV. J. Mol. Struct. 2003, 660, 1–13. DOI: 10.1016/S0022-2860(03)00418-6.
   Web of Science ®Google Scholar
• Ispikoudi, M.; Amvrazis, M.; Kontogiorgis, C.; Koumbis, A. E.; Litinas, K. E.; Hadjipavlou-Litina, D.; Fylaktakidou, K. C. Convenient Synthesis and Biological Profile of 5-Amino-Substituted 1,2,4-Oxadiazole Derivatives. Eur. J. Med. Chem. 2010, 45, 5635–5645. DOI: 10.1016/j.ejmech.2010.09.016.
   PubMed Web of Science ®Google Scholar
• dos Santos Filho, J. M.; Leite, A. C. L.; de Oliveira, B. G.; Moreira, D. R. M.; Lima, M. S.; Soares, M. B. P.; Leite, L. F. C. C. Design, Synthesis and Cruzain Docking of 3-(4-Substituted-Aryl)-1,2,4-oxadiazole-N-Acylhydrazones as anti-Trypanosomacruzi Agents. Bioorg. Med. Chem. 2009, 17, 6682–6691. DOI: 10.1016/j.bmc.2009.07.068.
   PubMed Web of Science ®Google Scholar
• Bokach, N. A.; Khripoun, A. V.; Kukushkin, V. Y.; Haukka, M.; Pombeiro, A. J. L. A Route to 1,2,4-Oxadiazoles and Their Complexes via Platinum-Mediated 1,3-Dipolar Cycloadditi on of Nitrile Oxides to Organonitriles. Inorg. Chem. 2003, 42, 896–903. DOI: 10.1021/ic026103v.
   PubMed Web of Science ®Google Scholar
• Jeschke, P.; Wachendorff-Neumann, U.; Erdelen, C.; Mencke, N.; Turberg, A. Ger. Offen. DE 4;401,107 (Cl.C07D271/06), 20 Jul 1995, Appl. 17 Jan 1994, 40pp. Chem. Abstr. 1995, 123, 340135t.
   Google Scholar
• Lueg, C.; Schepmann, D.; Günther, R.; Brust, P.; Wünsch, B. Development of Fluorinated CB2 Receptor Agonists for PET Studies. Bioorg. Med. Chem. 2013, 21, 7481–7498. DOI: 10.1016/j.bmc.2013.09.040.
   PubMedGoogle Scholar
• Upare, A. A.; Gadekar, P. K.; Sivaramakrishnan, H.; Naik, N.; Khedkar, V. M.; Sarkar, D.; Choudhari, A.; Roopan, S. M. Design, Synthesis and Biological Evaluation of €-5-Styryl-1,2,4-Oxadiazoles as anti-Tubercular Agents. Bioorg. Chem. 2019, 86, 507–512. DOI: 10.1016/j.bioorg.2019.01.054.
   PubMed Web of Science ®Google Scholar
• Manfredini, S.; Lampronti, I.; Vertuani, S.; Solaroli, N.; Recanatini, M.; Bryan, D.; McKinney, M. Design, Synthesis and Binding at Cloned Muscarinic Receptors of N-[5- (1′-Substituted-Acetoxymethyl)-3-Oxadiazolyl] and N-[4-(1′-Substituted-Acetoxymet Hyl)-2-Dioxolanyl]Dialkyl Amines. Bioorg. Med. Chem. 2000, 8, 1559–1566. DOI: 10.1016/S0968-0896(00)00092-4.
   PubMed Web of Science ®Google Scholar
• Leite, A. C. L.; Vieira, R. F. F.; Moreira, D. R. M.; Brondani, D. J.; Srivastava, R. M.; Silva, V. F.; Junior, M. A. M. Genotoxic Activity of 3-[3-Phenyl-1,2,4-Oxadiazol-5-yl]Propionic Acid and Its Peptidyl Derivatives Determined by Ames and SOS Response Tests. Mutat. Res. 2005, 588, 166–171. DOI: 10.1016/j.mrgentox.2005.10.006.
   PubMed Web of Science ®Google Scholar
• Clitherow, J. W.; Beswick, P.; Irving, W. J.; Scopes, D. I. C.; Barnes, J. C.; Clapham, J.; Brown, J. D.; Evans, D. J.; Hayes, A. G. Novel 1, 2, 4-Oxadiazoles as Potent and Selective Histamine H3 Receptor Antagonists. Bioorg. Med. Chem. Lett. 1996, 6, 833–838. DOI: 10.1016/0960-894X(96)00122-9.
   Web of Science ®Google Scholar
• Cottrell, D. M.; Capers, J.; Salem, M. M.; DeLuca-Fradley, K.; Croft, S. L.; Werbovetz, K. A. Antikinetoplastid Activity of 3-Aryl-5-Thiocyanatomethyl-1,2,4-Oxadiazoles. Bioorg. Med. Chem. 2004, 12, 2815–2824. DOI: 10.1016/j.bmc.2004.03.054.
   PubMed Web of Science ®Google Scholar
• Ono, M.; Haratake, M.; Saji, H.; Nakayama, M. Development of Novel β-Amyloid Probes Based on 3,5-Diphenyl-1,2,4-Oxadiazole. Bioorg. Med. Chem. 2008, 16, 6867–6872. DOI: 10.1016/j.bmc.2008.05.054.
   PubMed Web of Science ®Google Scholar
• Axel, K.; Jürgen, E. Pharmaceutical Substances: Syntheses, Patents, Applications; Stuttgart, Germany: Thieme Chemistry, 2001.
   Google Scholar
• Rudrapal, M.; Celik, I.; Khan, J.; Ansari, M. A.; Alomary, M. N.; Alatawi, F. A.; Yadav, R.; Sharma, T.; Tallei, T. E.; Pasala, P. K.; et al. Identification of Bioactive Molecules from Triphala (Ayurvedic Herbal Formulation) as Potential Inhibitors as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) through Computational Investigations. J. King Saud Univ. Sci. 2022, 34, 101826. DOI: 10.1016/j.jksus.2022.101826.
   PubMed Web of Science ®Google Scholar